Latest Biomarker Stories
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for
Two innovative medical technology companies, InSilico Medicine, Inc.
Metanomics Health GmbH Launches “Industry First” White Paper On Novel Quality Control Assay Titled “Benefits of Metabolomics-Based Quality Control of Human Plasma Samples for Clinical Biobanking”
Ancon Medical utilizes nanoparticle technology in efficiently-designed device providing advanced disease screening capabilities with unprecedented sensitivity Bloomington,
ADELAIDE, Australia, April 10, 2015 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced that it will present a poster with new data on the DisrupTOR-1
GHENT, Belgium and LAUSANNE, Switzerland, April 9, 2015 /PRNewswire/ -- ~ CEO of MDxHealth becomes new independent director ~ MyCartis NV today announced
According to the new report from BCC Research, the global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a
LONDON, March 30, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014.
According to a new study in the journal Nature, researchers at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) are developing a system capable of delivering high-resolution data while penetrating deep into the body.
Multi-Disciplinary Guidance Document Focuses on Using Molecular Markers to Optimize Patient Care CHICAGO and NORTHFIELD, Ill. and BETHESDA, Md.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.
More Images (2 images) »